Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Sergey Terushkin, MD, FACS One of the biggest misunderstandings is confusing the return of an old injury with withdrawal
Investigating the same primary endpoint, TRANSCEND-T2D-2 (NCT06260722) will compare retatrutide to semaglutide in people with inadequately controlled T2D (treated with oral glucose-lowering treatments) over 26 months
Hypoglycemia is a term that describes dangerously low blood sugar, which manifests with shaking, sweating, dizziness, hunger, confusion, and loss of consciousness
The Habit of Being: Letters of Flannery O'Connor
US$ 21.26
US$ 28.01
US$ 22.42
US$ 25.32
